JK1201I

· JenKem Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JK1201I, covering 2022-01-05 to 2022-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of JK1201I in Patients With SCLC [Phase 1, Phase 2]